Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis

NCT04885972 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Knee Osteoarthritis
Knee Pain Chronic

Interventions

DRUG: Resiniferatoxin
DRUG: Zilretta
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.